The cJun N-terminal kinase (JNK) signal transduction pathway is implicated in the regulation of neuronal function. JNK is encoded by three genes that play partially redundant roles. Here we report the creation of mice with targeted ablation of all three Jnk genes in neurons. Compound JNK-deficient neurons are dependent on autophagy for survival. This autophagic response is caused by FoxO-induced expression of Bnip3 that displaces the autophagic effector Beclin-1 from inactive Bcl-XL complexes. These data identify JNK as a potent negative regulator of FoxO-dependent autophagy in neurons.
The cJun N-terminal kinases (JNKs) are encoded by three genes (Davis 2000) . Two of these genes (Jnk1 and Jnk2) are expressed ubiquitously, while the Jnk3 gene is selectively expressed in neurons (Gupta et al. 1996) . Compound mutation of these Jnk genes causes early embryonic lethality in mice (Kuan et al. 1999; Sabapathy et al. 1999 ). Consequently, studies of JNK deficiency in neurons have focused on an analysis of mice with partial loss of JNK (Davis 2000; Weston and Davis 2007) . These studies have demonstrated isoform-specific functions of JNK in neurons (Brecht et al. 2005) .
It is established that JNK plays an important role in the regulation of microtubule stability in neurons. JNK-induced phosphorylation of microtubule-associated proteinsincluding Doublecortin (Gdalyahu et al. 2004 ), MAP1B (Chang et al. 2003; Barnat et al. 2010 ), MAP2 (Chang et al. 2003) , the stathmin protein family of microtubuledestabilizing proteins (Tararuk et al. 2006) , and Tau (Yoshida et al. 2004 )-may influence microtubule function. This action of JNK is important for neurite formation. Thus, JNK contributes to bone morphogenic proteinstimulated dendrite formation (Podkowa et al. 2010) , the structure of dendritic architecture (Coffey et al. 2000; Bjorkblom et al. 2005) , axodendritic length (Tararuk et al. 2006) , and axonal regeneration (Barnat et al. 2010 ). Moreover, JNK can regulate kinesin-mediated fast axonal transport on microtubules (Morfini et al. 2006 (Morfini et al. , 2009 ) and contributes to the regulation of synaptic plasticity (Chen et al. 2005; Zhu et al. 2005; Li et al. 2007 ; Thomas et al. 2008) . Together, these data demonstrate that JNK plays a key role in the physiological regulation of neuronal activity (Waetzig et al. 2006) .
The JNK signaling pathway has also been implicated in stress-induced apoptosis (Kuan et al. 1999; Tournier et al. 2000) , including neuronal death in models of excitotoxicity (Yang et al. 1997 ) and stroke (Kuan et al. 2003; Pirianov et al. 2007 ). This JNK-induced apoptotic response is mediated, in part, by the expression and/or phosphorylation of members of the Bcl2-related protein family (Weston and Davis 2007; Hubner et al. 2008; Morel et al. 2009; Hubner et al. 2010) . These data indicate that JNK plays a critical role during the injury response associated with neurodegeneration and stroke.
The dual role of JNK in mediating both physiological responses (e.g., neurite development) and pathological responses (e.g., neuronal injury) requires that the actions of JNK are context-specific (Waetzig and Herdegen 2005) . These effects of JNK may be mediated by compartmentalization of specific pools of JNK in different subcellular locations or within different signaling complexes (Coffey et al. 2000) . JNK may also cooperate with other signal transduction pathways to generate context-specific responses (Lamb et al. 2003) . However, the fundamental role of JNK in neurons and the mechanisms that account for these divergent biological responses to JNK signaling remain poorly understood.
Studies of mice with deficiency of one Jnk gene have provided a foundation for current knowledge of the role of JNK in neurons. However, partial loss of JNK expression represents a limitation of these studies because of redundant functions of JNK isoforms (Tournier et al. 2000; Jaeschke et al. 2006) . Creation of a model of compound JNK deficiency is important because compound JNK deficiency represents a more relevant model for understanding the effects of pharmacological JNK inhibition than deficiency of a single JNK isoform. JNK inhibitors have been identified that may be useful for the treatment of neurodegenerative diseases and stroke (Borsello et al. 2003; Hirt et al. 2004; Repici et al. 2007; Carboni et al. 2008; Esneault et al. 2008; Wiegler et al. 2008; Probst et al. 2011) . A model of neuronal compound JNK deficiency is required to test whether the actions of these drugs are mediated by loss of JNK function. Moreover, an experimental model of compound JNK deficiency in neurons would provide insight into the physiological role of JNK in wild-type neurons.
The purpose of this study was to examine the properties of neurons with simultaneous ablation of the Jnk1, Jnk2, and Jnk3 genes. We report the creation and characterization of mice with triple deficiency of neuronal JNK isoforms in vivo and in primary cultures in vitro.
Results

Establishment of neurons with compound JNK deficiency in vitro
To examine the function of JNK in neurons, we prepared primary cerebellar granule neurons (CGNs) from mice with conditional Jnk alleles. Cre-mediated deletion of conditional Jnk resulted in neurons that lack expression of JNK ( Fig. 1A,B ) and exhibit defects in the phosphorylation of the JNK substrates cJun (Davis 2000) and neurofilament heavy chain (Fig. 1C,D; Brownlees et al. 2000) . These triple Jnk knockout (JNK TKO ) neurons exhibited altered morphology, including hypertrophy (Figs. 1E-G; Supplemental Fig. S1 ). Immunofluorescence analysis using an antibody to Tau (data not shown) and Ankyin G demonstrated the presence of hypertrophic axons (Fig. 1H) .
The JNK signaling pathway is implicated in microtubule stabilization and the regulation of axodendritic morphology (Coffey et al. 2000; Chang et al. 2003; Bjorkblom et al. 2005; Tararuk et al. 2006; Barnat et al. 2010) . JNK inhibition may therefore increase microtubule instability and cause neurite retraction. Indeed, the JNK TKO neuronal hypertrophy was associated with a reduction in the number of dendrites ( Fig. 1H; Supplemental Fig. S1 ). To test whether JNK TKO neurons exhibited increased microtubule instability, we examined the presence of stable microtubules containing detyrosinated Tubulin by immunofluorescence analysis (Schulze et al. 1987; Webster et al. 1987; Khawaja et al. 1988 ). Contrary to expectations, no decrease in microtubules with detyrosinated Tubulin was detected in JNK TKO neurons compared with control neurons Figure 1 . Establishment of JNK-deficient neurons. Wild-type (control) and Jnk1 LoxP/LoxP Jnk2 À/À Jnk3 À/À CGNs were infected with Ad-cre at 3 d of culture in vitro (DIV) and then examined at 10 DIV. (A) Genotype analysis of JNK TKO neurons. The floxed Jnk1 and deleted Jnk1 alleles are detected as 1095-base-pair (bp) and 395-bp PCR products, respectively. (B) Extracts prepared from JNK TKO neurons were examined by immunoblot analysis using antibodies to JNK and a-Tubulin. (C) Control and JNK TKO neurons were examined at 10 DIV by immunoblot analysis using antibodies to phospho-neurofilament H and a-Tubulin. (D) Control and JNK TKO neurons were examined by immunofluorescence microscopy by staining with DAPI and antibodies to bIII tubulin and phospho-Ser 63 cJun. Bar, 20 mm. (E) Control and JNK TKO neurons were examined by phase-contrast microscopy. Bar, 75 mm. (F) Control and JNK TKO neurons were stained with calcein-am ester and examined by fluorescence microscopy. Bar, 65 mm. (G) Wild-type (control) and JNK TKO neurons were stained with Mitotracker Red at 10 DIV and imaged by differential interference contrast (DIC) and fluorescence microscopy. Bar, 8 mm. (H) Control and JNK TKO neurons were examined by immunofluorescence microscopy by staining with DAPI and antibodies to bIII tubulin and Ankyrin G. Bar, 20 mm. Fig. S2 ). Together, these data confirm that JNK regulates neuronal morphology, but the mechanism may be only partially accounted for by altered microtubule stability.
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Comparison of control and JNK TKO neurons demonstrated that JNK deficiency caused a marked increase in life span during culture in vitro ( Fig. 2A ; Supplemental  Fig. S3A ). To confirm that the loss of JNK activity increased life span, we employed a chemical genetic strategy using neurons prepared from mice with germline point mutations that confer sensitivity of JNK to the predesigned small molecule drug 1NM-PP1 (Jaeschke et al. 2006 ). This chemical genetic analysis confirmed that JNK inhibition caused both hypertrophy and increased neuronal viability in vitro ( Fig. 2B; Supplemental Fig. S3B ).
A defect in transport might contribute to the axonal hypertrophy of JNK TKO neurons (Griffin and Watson 1988) . Indeed, it is established that JNK acts as a negative regulator of kinesin-mediated fast axonal transport (Morfini et al. 2006 (Morfini et al. , 2009 . These data suggest that JNK TKO neurons may exhibit altered kinesin-mediated transport. We found an accumulation of mitochondria ( Fig.1G Fig. S7 ). This loss of transport in JNK TKO neurons contrasts with expectations that JNK deficiency might increase transport (Morfini et al. 2006 (Morfini et al. , 2009 . It is established that fast transport of mitochondria is mediated by the conventional kinesin KIF5b (Tanaka et al. 1998 ). However, no decrease in Kif5b expression was detected in JNK TKO CGNs (Supplemental Fig. S8 ). A more general defect in trafficking may therefore account for the mislocalization of organelles in JNK TKO neurons.
Neuronal JNK deficiency causes increased autophagy in vitro
Live-cell imaging indicated that the morphology of mitochondria in JNK TKO neurons was different than control neurons ( Fig. 1G ). Electron microscopy confirmed that JNK TKO mitochondria were larger than control mitochondria (Supplemental Fig. S9 ). Numerous double-membrane structures, morphologically similar to autophagosomes, were detected in JNK TKO neurons, but not in control neurons. The presence of large numbers of autophagosomes in JNK TKO neurons suggests that these cells may exhibit increased autophagy. Indeed, biochemical analysis demonstrated that an increased amount of the autophagic effector protein Atg8/LC3b was processed by conjugation of phosphatidylethanolamine to the C terminus of the LC3b-I form to create LC3b-II, which is tightly associated with the autophagosomal membrane (Kabeya et al. 2004; Sou et al. 2008) in JNK TKO neurons compared with control neurons (Fig. 3A ). Atg8/LC3b expression was increased in JNK TKO neurons (Fig. 3A ,E), and Atg8/LC3b was redistributed from a location primarily in the soma of control neurons to the neurites of JNK TKO neurons (Fig. 3D ). The Atg8/LC3b immunofluoresence detected in JNK TKO neurons was punctate (Supplemental Fig. S10 ), consistent with localization to autophagosomal membranes. Moreover, the p62/SQSTM1 protein, which directly binds the autophagic effector Atg8/LC3 (Pankiv et al. 2007) , was detected in wild-type neurons but not in JNK TKO neurons (Fig. 3A) .
The loss of p62/SQSTM1 suggests that autophagic flux is increased in JNK TKO neurons compared with control neurons (Klionsky et al. 2008) . To confirm this conclusion, we examined the effect of lysosomal inhibition on the conversion of LC3b-I to LC3b-II. If the autophagic flux is increased, blocking autophagy should lead to increased accumulation of LC3b-II. Consistent with an increase in autophagic flux, we found that inhibition of autophagy caused a greater increase in LC3b-II in JNK TKO neurons compared with control neurons (Supplemental Fig. S11 ). Together, these data demonstrate the presence of an active autophagic response in JNK TKO neurons.
Autophagy may contribute to the increased survival of JNK TKO neurons (Hara et al. 2006; Komatsu et al. 2006 ). Indeed, studies using a pharmacological inhibitor Jnk2 M108G/M108G Jnk3 À/À CGNs were untreated (control) or infected with Ad-cre at 3 DIV and with the drug 1-NM-PP1 (1 mM) at 7 DIV (iJNK). The CGNs were examined using phase-contrast microscopy. Bar, 45 mm. (C) Wild-type (control) and JNK TKO CGNs infected with Ad-cre at 3 DIV were incubated without and with 1 mM chloroquine (CQ) at 11 DIV and then examined by phasecontrast microscopy at 12 DIV. Bar, 65 mm. Quantitative analysis of neuronal viability is presented in Supplemental Figure S3 . demonstrated that autophagy was required for the increased life span of JNK TKO neurons compared with control neurons (Fig. 2C; Supplemental Fig. S3 ). Moreover, RNAi-mediated knockdown of the autophagic effector Beclin-1 caused decreased survival of JNK TKO neurons, but not control neurons ( Fig. 4 ). Together, these data demonstrate that the survival of JNK TKO neurons depends on autophagy.
TORC1 does not mediate the effects of JNK deficiency on neuronal autophagy
The mTOR protein kinase complex TORC1 is a potent negative regulator of autophagy (Guertin and Sabatini 2007) . Decreased TORC1 activity in JNK-deficient neurons may therefore account for the observed increase in autophagy. To test TORC1 function, we examined the phosphorylation of the TORC1 substrate pSer 389 p70 S6K . We found that JNK deficiency did not alter the phosphorylation of this TORC1 substrate in neurons (Supplemental Fig. S12 ). These data demonstrate that JNK deficiency regulates autophagy by a TORC1-independent mechanism.
Increased autophagy in JNK-deficient neurons is mediated by a FoxO1/Bnip3/Beclin-1 pathway
The finding that JNK deficiency in neurons triggers an autophagic response ( Fig. 3) was unexpected, because studies of nonneuronal cells have implicated JNK in the induction of autophagy (Yu et al. 2004; Ogata et al. 2006; Wei et al. 2008) or as an effector of autophagy-associated cell death (Yu et al. 2004; Shimizu et al. 2010) . Indeed, we found that autophagy caused by serum withdrawal was compromised in compound mutant fibroblasts that lack JNK expression (Supplemental Fig. S13 ). This finding markedly contrasts with the effect of compound JNK deficiency in neurons to induce spontaneous autophagy (Fig. 3) . These data indicate that the role of JNK in autophagy suppression may be restricted to neurons.
To test whether the autophagic mediator Beclin-1 may be relevant to autophagy caused by JNK deficiency in neurons, we examined the effect of RNAi-mediated knockdown of Beclin-1 expression. Knockdown of Beclin-1 suppressed biochemical markers of autophagy in JNK TKO neurons, including increased LC3b-II and decreased p62/SQSTM1 (Fig. 4) . These data demonstrate that Beclin-1 may mediate the effects of JNK deficiency to cause increased autophagy in neurons.
It is established that the JNK-regulated interaction of Bcl2 with the BH3 domain of Beclin-1 may contribute to autophagy (Wei et al. 2008) . We therefore examined the interaction of Beclin-1 with Bcl2 family proteins in neurons. No coimmunoprecipitation of Beclin-1 with Bcl2 was detected in control neurons. However, Beclin-1 was found to coimmunoprecipitate with Bcl-XL in control neurons, but this interaction was markedly suppressed in JNK TKO neurons (Fig. 3B ). The BH3 domain-binding activity of Bcl-XL is negatively regulated by phosphorylation of Bcl-XL on Ser 62 (Upreti et al. 2008 ), but no increase in Bcl-XL phosphorylation was detected in JNK TKO neurons by immunoblot analysis with a phospho-specific antibody (data not shown). An alternative mechanism must therefore mediate the dissociation of Beclin-1. Release of Beclin-1 from Bcl-XL complexes could be mediated by competition with another BH3 domain protein. Indeed, we found that JNK TKO neurons expressed increased amounts of Bnip3, a BH3-only member of the Bcl2 protein family (Fig. 3B ). Coimmunoprecipitation analysis demonstrated that the release of Beclin-1 from Bcl-XL complexes was associated with increased interaction of Bcl-XL with Bnip3 (Fig. 3B) .
The Bnip3 gene is known to be a target of FoxO transcription factors that also increase the expression of the autophagy-related genes Atg8/Lc3b and Atg12 (Salih and Brunet 2008) . The increased expression of these genes in JNK TKO neurons (Fig. 3A,B ,D,E) suggests that JNK deficiency leads to FoxO activation. Indeed, gene expression analysis demonstrated increased FoxO1 mRNA and protein expression in JNK TKO neurons ( Fig. 3C-E) . To test whether FoxO1 contributes to the increased autophagy detected in JNK TKO neurons, we examined the effect of RNAi-mediated knockdown of FoxO1. Knockdown of FoxO1 in JNK TKO neurons caused decreased expression of Bnip3 and Atg genes, suppressed the increase in LC3b-II and the decrease in p62/SQSTM1, and caused decreased neuronal survival (Fig. 5 ). These data demonstrate that FoxO1 is required for the increased autophagy and survival of JNK TKO neurons.
Cytoplasmic sequestration is a major mechanism of FoxO1 regulation by signal transduction pathways, including AKT (Salih and Brunet 2008) . We found a small increase AKT phosphorylation on Thr 308 and Ser 473 in JNK TKO neurons (Fig. 3C) , indicating that AKT activity may be moderately increased in JNK TKO neurons compared with control neurons. Nevertheless, we found increased nuclear localization of FoxO1 in JNK TKO neurons compared with control neurons (Fig. 3F ). This nuclear redistribution of FoxO1 in JNK TKO neurons was associated with increased phosphorylation of FoxO1 on Ser 246 (Fig. 3C ), a site that dominantly induces nuclear accumulation of FoxO1 and is phosphorylated by cyclin-dependent protein kinases (CDKs) (Yuan et al. 2008) . Abortive cell cycle re-entry has been observed during neurodegenerative processes (Kim and Bonni 2008) , including stroke (Kuan et al. 2004) . Indeed, we found that CDK2 was activated in JNK TKO neurons compared with control neurons (Fig.  3C ). To test whether increased CDK activity contributes to the phenotype of JNK TKO neurons, we examined the effect of CDK inhibition on control and JNK TKO neurons. We found that CDK inhibition suppressed the increase in Bnip3 and FoxO1 expression detected in JNK TKO neurons (Fig. 6A) . Moreover, CDK inhibition suppressed the autophagy-related increase in LC3b-II, decrease in p62/ SQSTM1, and survival of JNK TKO neurons compared with control neurons (Fig. 6B-E) . These data confirm 
Mice with compound JNK deficiency in neurons in vivo
We tested the effect of transgenic expression of Cre recombinase in the brain of mice with floxed Jnk on neuronal function in vivo. Initial studies using Nestin-Cre mice demonstrated that triple JNK deficiency in neuronal progenitor cells caused early embryonic death (data not shown). Similarly, expression of Cre recombinase in a more limited region of the brain (telencephalon) using Foxg1-Cre transgenic mice also caused early embryonic death (data not shown). The early death of these JNK TKO mice precluded analysis of the effects of triple JNK deficiency on the brain. We therefore examined the effect of Cre expression in a subset of neurons that are nonessential for mouse survival. A mouse strain with Cre recombinase inserted in the Pcp2 gene expresses Cre recombinase in cerebellar Purkinje cells (Barski et al. 2000) . This Pcp2-Cre strain enabled the creation of viable mice with triple neuronal deficiency of JNK1, JNK2, and JNK3 (Fig. 7) . Purkinje cell defects represent one cause of cerebellar ataxia (Grusser-Cornehls and Baurle 2001), but ataxia was not detected in mice with compound JNK-deficient Purkinje cells that were examined (Figs. 7, 8 ). This observation indicates that Purkinje cells can function without the JNK signaling pathway.
Immunocytochemistry analysis demonstrated the loss of JNK protein in the Purkinje cell layer of the cerebellum (Fig. 7A) , and genotype analysis of cerebellar DNA led to the identification of loss-of-function alleles of Jnk1, Jnk2, and Jnk3 (Fig. 7B) . The JNK TKO Purkinje cells exhibited reduced dendritic arborization (Supplemental Fig.  S14 ). Immunofluorescence analysis using an antibody to Calbindin D-28k indicated the presence of hypertrophic Purkinje cell axons in deep cerebellar nuclei (DCN) (Fig.  7C) . These hypertrophic axons were also identified in sections of the JNK TKO DCN stained with H&E ( Fig. 7D) , by immunohistochemical staining with an antibody to Calbindin D-28k (Fig. 7D) , and staining using the Golgi reagent (Supplemental Fig. S14 ). Staining with an antibody to GFAP demonstrated that the axonal hypertrophy was associated with reactive gliosis (Fig. 7D ). Electron microscopy confirmed the hypertrophy of myelinated Purkinje cell axons in the DCN of JNK TKO mice ( Fig.  7E; Supplemental Fig. S15 ). Quantitative image analysis demonstrated that the cross-sectional area of Purkinje cell axons was significantly larger in the DCN of JNK TKO mice compared with control mice (Fig. 7F ). Fewer axonal mitochondria and increased numbers of autophagosomes were detected in JNK TKO mice compared with control mice (Fig. 7F) . In contrast, the size of both autophagosomes and mitochondria were increased in JNK TKO mice compared with control mice (Fig. 7F ).
Neuronal JNK deficiency causes increased autophagy in vivo
The observation that compound JNK deficiency causes increased autophagy in primary cultures of neurons in vitro (Fig. 3) suggests that JNK may suppress neuronal autophagy in vivo. To test this hypothesis, we examined autophagy in mice with triple deficiency of JNK1, JNK2, and JNK3 in Purkinje cells (Fig. 8) . Electron microscopy demonstrated that autophagy was influenced by compound JNK deficiency because the size of axonal autophagosomes in the DCN was significantly increased compared with control mice (Fig. 7F) . However, the altered size of autophagosomes could be caused by either an increase or a decrease in neuronal autophagy. We therefore examined the amount of p62/SQSTM1 protein (which directly binds the autophagic effector Atg8/LC3) (Pankiv et al. 2007) in Purkinje cells by immunohistochemistry. The p62/SQSTM1 protein was detected in the Purkinje cell soma of control mice, but not in mice with compound deficiency of JNK in Purkinje cells (Fig. 8A) . This loss of p62/SQSTM1 suggests that autophagic flux is increased in JNK TKO neurons compared with control neu-rons (Klionsky et al. 2008 ). The increased autophagy was associated with nuclear phosphorylation of the transcription factor FoxO1 on the activating site Ser 246 (Fig. 8A ) and increased expression of Bnip3 and Atg12 (Fig. 8B) . The amount of LC3b in the Purkinje cell soma was moderately increased in compound JNK-deficient Purkinje cells (Fig. 8B) , but a large increase in LC3b was detected in Purkinje cell axons within the DCN (Fig. 8C ). Together, these data indicate that the FoxO1-Bnip3 pathway that induces autophagy is activated in compound JNK-deficient Purkinje cells in vivo.
Discussion
Studies of nonneuronal cells have implicated JNK in the induction of autophagy (Yu et al. 2004; Ogata et al. 2006; Wei et al. 2008) . Indeed, we confirmed the conclusion that JNK can contribute to increased autophagy by examining primary mouse embryonic fibroblasts (MEFs) with compound JNK deficiency ( Supplemental Fig. S13 ). The mechanism of JNK-induced autophagy may be mediated by phosphorylation of Bcl2 by JNK and the subsequent release of the autophagic effector Beclin-1 (Wei et al. 2008) . The sites of JNK phosphorylation on Bcl2 (Yamamoto et al. 1999 ) are conserved in the related protein Bcl-XL (Kharbanda et al. 2000; Upreti et al. 2008) . This conservation suggests that phosphorylation of Bcl2 and Bcl-XL is functionally important. Phosphorylation of Bcl2 and Bcl-XL by JNK (Yamamoto et al. 1999; Kharbanda et al. 2000) and other protein kinases (Tournier et al. 2001; Terrano et al. 2010 ) may represent an important mechanism of autophagy regulation (Wei et al. 2008) . Indeed, the properties of JNK as a stress-responsive kinase provide an elegant mechanism for coupling stress exposure to the induction of autophagy (Ogata et al. 2006) .
The JNK signaling pathway suppresses neuronal autophagy
Studies of nonneuronal cells demonstrate that JNK is markedly activated from a low basal state when cells are exposed to stress (Davis 2000) . However, JNK is regulated very differently in neurons. JNK1 remains constitutively activated under basal conditions, while JNK2 and JNK3 exhibit low basal activity and are stress-responsive (Coffey et al. 2000 (Coffey et al. , 2002 . The proautophagy role of JNK in nonneuronal cells has been reported to be mediated by JNK1 (Wei et al. 2008) . It is therefore intriguing that JNK1 is constitutively activated in neurons. Based on studies of nonneuronal cells (Wei et al. 2008) , the constitutive activation of JNK1 in neurons should cause autophagy. A mechanism must therefore exist to prevent autophagy activation by constitutively activated JNK1 in neurons. Although the mechanism is unclear, these considerations indicate that neurons are refractory to the proautophagy JNK1 signaling pathway that has been identified in nonneuronal cells (Wei et al. 2008) .
Our analysis of compound JNK-deficient neurons demonstrates that JNK regulates neuronal autophagy. In contrast to the proautophagy role of JNK nonneuronal cells, neuronal JNK acts to suppress autophagy. Loss of neuronal JNK function causes engagement of a transcriptional program that leads to increased expression of autophagyrelated genes and the induction of an autophagic response (Fig. 3) . One consequence of autophagy induction caused by JNK deficiency is improved neuronal survival (Figs. 2;  Supplemental Fig. S3 ).
JNK can act as a molecular switch that regulates FoxO-induced autophagy and apoptosis
FoxO transcription factors are implicated in the induction of both cell death (apoptosis) and cell survival (autophagy) responses (Salih and Brunet 2008) . The results of this study identify JNK as a signaling molecule that may contribute to the coordination of these divergent responses to FoxO transcription factor activation.
FoxO activation in neurons leads to the expression of the target gene Bim, a proapoptotic BH3-only protein, and causes cell death (Gilley et al. 2003) . JNK activation in neurons promotes expression of Bim, most likely because JNK-dependent AP-1 activity is required for Bim expression (Whitfield et al. 2001) . Moreover, JNK phosphorylates Bim on an activating site (Hubner et al. 2008) , and also causes the release of Bim from complexes with the anti-apoptotic Bcl2 family protein Mcl-1 (Morel et al. 2009 ). Together, these processes initiate JNK-dependent apoptosis. JNK inhibition can therefore prevent neuronal cell death. Indeed, small molecule inhibitors of JNK cause neuroprotection in models of neurodegenerative disease (Borsello et al. 2003; Hirt et al. 2004; Repici et al. 2007; Carboni et al. 2008; Esneault et al. 2008; Wiegler et al. 2008; Probst et al. 2011) .
Activation of FoxO transcription factors can also cause increased expression of autophagy-related genes, including Atg8/Lc3b, Atg12, and Bnip3 (Salih and Brunet 2008) . While JNK cooperates with FoxO to increase proapoptotic Bim expression (Whitfield et al. 2001) , JNK deficiency prevents induction of Bim expression ( Fig. 3E) and promotes a survival response that is mediated by increased FoxO-dependent expression of the autophagy-related target genes Atg8/Lc3b, Atg12, and Bnip3 (Figs. 3E, 5B-D). Indeed, inhibition of autophagy in JNK-deficient neurons causes rapid death (Figs. 2C, 4C ). This neuronal survival response is relevant to stroke models in which neuronal death is mediated by a JNK-dependent mechanism (Kuan et al. 2003; Pirianov et al. 2007 ).
Together, these data demonstrate that cross-talk between the FoxO and JNK signaling pathways leads to neuronal death. In contrast, loss of JNK promotes FoxOinduced survival mediated by increased autophagy. JNK therefore acts as a molecular switch that defines the physiological consequence of FoxO activation in neurons.
Conclusions
JNK is implicated in the induction of autophagy in nonneuronal cells. However, JNK1 is constitutively activated in neurons, and these cells are refractory to JNKinduced autophagy. Instead, JNK acts to suppress autophagy in neurons by inhibiting FoxO-induced expression of autophagy-related genes (e.g., Atg8/Lc3b, Atg12, and Bnip3) and increasing the expression of proapoptotic genes (e.g., Bim). JNK inhibition causes neuroprotection that is mediated by loss of proapoptotic gene expression and increased autophagy.
Materials and methods
Mice
We described Jnk1 À/À mice (Dong et al. 1998) , Jnk1 LoxP/LoxP mice (Das et al. 2007 ), Jnk2 À/À mice , Jnk2 M108G/M108G mice (Jaeschke et al. 2006) , and Jnk3 À/À mice (Yang et al. 1997) . B6.129-Tg(Pcp2-cre)2Mpin/J mice (Barski et al. 2000) , B6.Cg-Tg(Nes-cre)1Kln/J mice (Tronche et al. 1999) , and B6.129P2(Cg)-Foxg1 tm1(cre)Skm /J mice (Eagleson et al. 2007) were obtained from The Jackson Laboratories. These mice were backcrossed to the C57BL/6J strain (Jackson Laboratories) and were housed in a facility accredited by the American Association for Laboratory Animal Care. The animal studies were approved by the Institutional Animal Care and Use Committee of the University of Massachusetts Medical School.
Genotype analysis
Genomic DNA was examined by PCR analysis using primers to identify wild-type and Jnk1 À (Dong et al. 1998 
Tissue culture
Wild-type and Jnk1 À/À Jnk2 À/À MEFs (Tournier et al. 2000) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (Invitrogen). Primary cultures of CGNs were prepared from postnatal day 6 mice (Kennedy et al. 2007 ). The CGNs were cultured 2 d in vitro with neurobasal medium containing B27 supplements, 1% glutamine, 1% penicillin/streptomycin, 25 mM glucose, and 25 mM KCl; seeded in poly-D-lysine/laminin-coated chamber slides (Becton Dickenson) or dishes (MatTek); and then infected with adenovirus-Cre (Ad5CMVCre; ;100 multiplicity of infection) (Gene Transfer Vector Core, University of Iowa) each day for 3 d. RNAi transfection studies were performed using the PepMute siRNA transfection reagent (SignaGen Laboratories) with 20 nM siRNA (NM_019584 or NM_019739, Dharmacon RNA Technologies) at 7 d of culture in vivo (DIV) and again at 8 DIV. Some cultures were treated with 1 mM 1-naphthylmethyl-4-amino-1-tert-butyl-3-(p-methylphenyl)pyrazolo[3,4-d]pyrimidine (1NM-PP1; Calbiochem), 1 mM chloroquine (Sigma), or 5 mM roscovitine (LC Laboratories). Neurons were also stained with calcein-am ester (Calbiochem) and imaged by confocal fluorescence microscopy with a Leica SP2 instrument (Kennedy et al. 2007 ).
RNA analysis
The expression of mRNA was examined by quantitative PCR analysis using a 7500 Fast Real-Time PCR machine (Applied Biosystems). TaqMan assays were used to quantitate Atg3
Kif5b (Mm00515276_m1), and Kif5c (Mm00515265_m1) (Applied Biosystems). The relative mRNA expression was normalized by measurement of the amount of Gapdh mRNA in each sample using TaqMan assays (Applied Biosystems).
Immunoblot analysis
Cell extracts were prepared using Triton lysis buffer (20 mM Tris at pH 7.4, 1% Triton X-100, 10% glycerol, 137 mM NaCl, 2 mM EDTA, 25 mM b-glycerophosphate, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 10 mg/mL aprotinin and leupeptin). Extracts (20-50 mg of protein) were examined by protein immunoblot analysis by probing with antibodies to LC3b (Novus Biologicals); p62/SQSTM1; CDK-2 (Santa Cruz Biotech-nology); AKT, pSer 308 -AKT, pSer 473 -AKT, Beclin-1, and Bcl-XL; pThr 389 -S6Kand S6K (Cell Signaling); JNK1/2 (BD Biosciences Pharmingen); phospho-neurofilament H (SMI-31R, Covance); phospho-serine, Bnip3, and FoxO1 (Abcam); and a-Tubulin (Sigma). The antibody to pSer 246 -FoxO1 was provided by Dr Azad Bonni (Yuan et al. 2008) . Immunecomplexes were detected by enhanced chemiluminescence (NEN). Immunoblot analysis of immunoprecipitates was performed using the One-Step Complete Immunoprecipitation-Western kit (Genescript Corp.).
Protein kinase assays
CDK2 activity was measured in an in vitro kinase assay using Rb-C fusion protein (Cell Signaling) as the substrate, and was quantitated using a PhosphorImager (Molecular Dynamics).
Immunofluorescence analysis
Primary CGNs were fixed by incubation with 4% paraformaldehyde for 1 h at room temperature and were permeabilized by incubation with 90% methanol containing 5% acetic acid for 5 min at À20°C. The slides were then blocked with 1% skim milk in phosphate-buffered saline (PBS) for 1 h at room temperature and incubated with antibodies to phospho-Ser 63 -cJun (Cell Signaling), detyrosinated Tubulin, Synaptophysin, and Tau (Chemicon); Ankyrin G and Lamp-1 (Santa Cruz Biotechnology); Snap25 and FoxO1 (Abcam); LC3b (Novus Biologicals); and bIII-Tubulin (Covance) in PBS supplemented with 1% skim milk overnight at 4°C. Secondary antibodies were conjugated with Alexa Fluor 488 or 546 (Molecular Probes) for 1 h at room temperature. CGNs were loaded with 100 nM MitoTracker Red (Molecular Probes) for 15 min at 37°C. All washed slides were mounted with VectaShield mounting medium with DAPI (Vector Laboratories) and were examined with a Leica SP2 laser-scanning confocal fluorescence microscope.
Time-lapse fluorescence microscopy
The CGNs were cultured 12 d in vitro in poly-D-lysine/laminincoated 35-mm glass-bottom microwell dishes (MatTek) and incubated with 100 nM MitoTracker Green (Molecular Probes) for 3 min. Time-lapse fluorescence microscopy of CGN cells was performed using a Nikon TE2000-E2 microscope with a Yokogawa CSU10b spinning-disk confocal scan head and custom laser launch, acoustical optical tunable filter (NEOS), and relay optics (Solamere Technology Group). Multiwavelength confocal Z-series were acquired with a Nikon 603 Plan Apo oil objective (NA = 1.4) and a QImaging Rolera MGi camera using the digitizer with electron multiplication gain. Metamorph software controlled the microscope hardware and image acquisition. The frames were collected every 3 secs with an exposure time of 100 msec.
Electron microscopy
Cells and tissue were fixed with 1.25% glutaraldehyde for 30 min at room temperature and with 2.5% gluteraldehyde in cacodylate buffer for 14 h at 4°C. The cells were then post-fixed with 1% (w/v) osmium tetraoxide in PBS, dehydrated, and embedded in Lx 112/Araldite 502 epoxy resin. Ultrathin sections were mounted on copper support grids in serial order, contrasted with lead citrate and uranyl acetate, and examined on a Philips CM 10 transmission electron microscope (Gangwani et al. 2005) . Quantitation of electron micrographs was performed by image analysis using the program AxioVision release 4.5 (Zeiss).
Immunohistochemical and immunofluorescence analysis of tissue sections
Perfusion fixation of mice was performed using PBS supplemented with 4% (w/v) paraformaldehyde. Fixed tissues (24 h at 4°C) were processed and embedded in paraffin, and 4-mm sections were prepared. These sections were stained with antibodies to JNK1/2 (BD Biosciences Pharmingen), p62/SQSTM1 (Abnova), or pSer 246 -FOXO1 (Yuan et al. 2008 ) using indirect immunoperoxidase detection (Xu et al. 1998) . Sections were also stained by immunofluorescence after paraffin removal using antigen retrieval with antigen unmasking solution (Vector Laboratories) and microwave irradiation. The sections were subsequently blocked with 0.4% Triton X-100, 10% goat serum, 150 mM NaCl, and 10 mM Tris-HCl (pH 7.4). Sections were incubated with antibodies to Calbindin D-28k (Sigma), Bnip3 and Atg12 (Cell Signaling), or LC3b (Novus Biologicals) for 12 h at 4°C and washed. Immunecomplexes were detected by incubation with secondary antibodies conjugated to Alexa Fluor 488 or 546 (Molecular Probes) for 1 h at 25°C. The slides were washed and mounted with VectaShield mounting medium with DAPI (Vector Laboratories) and examined with a Leica SP2 laser-scanning confocal fluorescence microscope. Frozen sections (100 mm) of the cerebellum were processed using the Rapid Golgi stain kit (FD NeuroTechnologies).
Statistical analysis
Differences between groups were examined for statistical significance using the Student's test or analysis of variance (ANOVA) with the Fisher's test.
